Home Zinc Finger Nucleases

Zinc Finger Nucleases

Latest
Zinc Finger Nucleases

Sangamo Researchers Show Improvements to Zinc Finger Nuclease Technology

Sangamo Therapeutics aims to position itself as a leader in the development of chimeric antigen receptor-modified regulatory T-cell (CAR-Treg) cell therapies for immunological diseases with its planned acquisition of TxCell. [Source: TxCell]
Zinc Finger Nucleases

Sangamo Looks to Expand into CAR-Treg Cell Therapies with TxCell Acquisition

Zinc Finger Nucleases

Kite, Sangamo Launch Up-to-$3B+ Cancer Cell Therapy Partnership

Zinc Finger Nucleases

Sangamo, Pfizer Partner on Gene Therapy for ALS, FTLD

Source: vchal/Getty Images
Zinc Finger Nucleases

Sangamo Genome Editing Trial, Assessing MPS II Candidate, Treats First Patient

Zinc Finger Nucleases

Genetically Engineered Pigs May Fly as Cancer Models

Zinc Finger Nucleases

A Tap of Radiation Enhances Gene Editing of Human Stem Cells

Source: © Willi - Fotolia.com
Zinc Finger Nucleases

Gene Editing Technique Boosts Patients’ HIV Resistance

Zinc Finger Nucleases

Genetic Bug Spray? Scientists Alter Mosquitoes’ Sense of Smell

Zinc Finger Nucleases

Sigma Divisions Establish Screening Technology Deals

123Page 1 of 3
Copyright © 2021 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up